
Ryan N. Henderson
Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )
| Most Active Art Unit | 3795 |
| Art Unit(s) | 3739, 3795, 3779 |
| Total Applications | 931 |
| Issued Applications | 516 |
| Pending Applications | 102 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12044776
[patent_doc_number] => 09822370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs'
[patent_app_type] => utility
[patent_app_number] => 14/485288
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 13
[patent_no_of_words] => 38312
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485288
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/485288 | Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs | Sep 11, 2014 | Issued |
Array
(
[id] => 11296770
[patent_doc_number] => 09504762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Adeno-associated virus factor VIII vectors'
[patent_app_type] => utility
[patent_app_number] => 14/482648
[patent_app_country] => US
[patent_app_date] => 2014-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 52
[patent_no_of_words] => 15922
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14482648
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/482648 | Adeno-associated virus factor VIII vectors | Sep 9, 2014 | Issued |
Array
(
[id] => 9912696
[patent_doc_number] => 20150067899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Multiple Inducible Gene Regulation System'
[patent_app_type] => utility
[patent_app_number] => 14/478668
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27239
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478668
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/478668 | Multiple Inducible Gene Regulation System | Sep 4, 2014 | Abandoned |
Array
(
[id] => 11962201
[patent_doc_number] => 20170266354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Cell-Based Device For Local Treatment With Therapeutic Protein'
[patent_app_type] => utility
[patent_app_number] => 15/508548
[patent_app_country] => US
[patent_app_date] => 2014-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11358
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508548
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508548 | Cell-Based Device For Local Treatment With Therapeutic Protein | Sep 3, 2014 | Abandoned |
Array
(
[id] => 9811991
[patent_doc_number] => 20150023934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'GENERATION OF EPITHELIAL CELLS AND ORGAN TISSUE IN VIVO BY REPROGRAMMING AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/471836
[patent_app_country] => US
[patent_app_date] => 2014-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 40999
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14471836
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/471836 | GENERATION OF EPITHELIAL CELLS AND ORGAN TISSUE IN VIVO BY REPROGRAMMING AND USES THEREOF | Aug 27, 2014 | Abandoned |
Array
(
[id] => 9917216
[patent_doc_number] => 20150072422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'METHOD OF ENHANCING PROLIFERATION AND/OR SURVIVAL OF MESENCHYMAL PRECURSOR CELLS (MPC)'
[patent_app_type] => utility
[patent_app_number] => 14/470769
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 28180
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/470769 | Method of increasing proliferation of bone marrow mononuclear cells expressing STRO1- | Aug 26, 2014 | Issued |
Array
(
[id] => 11006312
[patent_doc_number] => 20160203262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'System and Method for Determining Quality of Stem Cell Derived Cardiac Myocytes'
[patent_app_type] => utility
[patent_app_number] => 14/913925
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19048
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913925 | System and Method for Determining Quality of Stem Cell Derived Cardiac Myocytes | Aug 20, 2014 | Abandoned |
Array
(
[id] => 9857866
[patent_doc_number] => 20150037883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'METHOD FOR DERIVATION AND LONG-TERM ESTABLISHMENT OF GROUND STATE PLURIPOTENT EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/462598
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/462598 | METHOD FOR DERIVATION AND LONG-TERM ESTABLISHMENT OF GROUND STATE PLURIPOTENT EMBRYONIC STEM CELLS | Aug 18, 2014 | Abandoned |
Array
(
[id] => 10948944
[patent_doc_number] => 20140351965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'SWINE GENETICALLY MODIFIED WITH SPECIFICITY FOR LDL-R KNOCKOUT'
[patent_app_type] => utility
[patent_app_number] => 14/460841
[patent_app_country] => US
[patent_app_date] => 2014-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17858
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14460841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/460841 | SWINE GENETICALLY MODIFIED WITH SPECIFICITY FOR LDL-R KNOCKOUT | Aug 14, 2014 | Abandoned |
Array
(
[id] => 10996352
[patent_doc_number] => 20160193298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'THERAPEUTIC USE OF VEGF-C AND CCBE1'
[patent_app_type] => utility
[patent_app_number] => 14/911920
[patent_app_country] => US
[patent_app_date] => 2014-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8675
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911920 | THERAPEUTIC USE OF VEGF-C AND CCBE1 | Aug 12, 2014 | Abandoned |
Array
(
[id] => 10414655
[patent_doc_number] => 20150299665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'METHOD FOR REPROGRAMMING OF HUMAN DENTAL PULP CELL USING OCT4 AND SOX2 AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/340991
[patent_app_country] => US
[patent_app_date] => 2014-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 11251
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/340991 | METHOD FOR REPROGRAMMING OF HUMAN DENTAL PULP CELL USING OCT4 AND SOX2 AND USE THEREOF | Jul 24, 2014 | Abandoned |
Array
(
[id] => 10919161
[patent_doc_number] => 20140322180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'USE OF MESENCHYMAL STEM CELLS FOR COMPLETELY REPOPULATING HOST TISSUE'
[patent_app_type] => utility
[patent_app_number] => 14/330084
[patent_app_country] => US
[patent_app_date] => 2014-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8953
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330084
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/330084 | USE OF MESENCHYMAL STEM CELLS FOR COMPLETELY REPOPULATING HOST TISSUE | Jul 13, 2014 | Abandoned |
Array
(
[id] => 11913738
[patent_doc_number] => 09781909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Mito-Ob: a transgenic mouse model for obesity'
[patent_app_type] => utility
[patent_app_number] => 14/328888
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8685
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328888
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/328888 | Mito-Ob: a transgenic mouse model for obesity | Jul 10, 2014 | Issued |
Array
(
[id] => 10797099
[patent_doc_number] => 20160143256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'MRAP2 KNOCKOUTS'
[patent_app_type] => utility
[patent_app_number] => 14/903621
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22950
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903621 | MRAP2 KNOCKOUTS | Jul 8, 2014 | Abandoned |
Array
(
[id] => 10521229
[patent_doc_number] => 09247721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Transgenic non-human animal comprising a mutant alpha-synuclein'
[patent_app_type] => utility
[patent_app_number] => 14/326039
[patent_app_country] => US
[patent_app_date] => 2014-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 25712
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326039
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/326039 | Transgenic non-human animal comprising a mutant alpha-synuclein | Jul 7, 2014 | Issued |
Array
(
[id] => 10912290
[patent_doc_number] => 20140315307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'MIXED POPULATION OF CELLS DERIVING FROM ADIPOSE TISSUE AND METHODS OF ISOLATING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/322233
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12396
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322233
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/322233 | MIXED POPULATION OF CELLS DERIVING FROM ADIPOSE TISSUE AND METHODS OF ISOLATING AND USING THE SAME | Jul 1, 2014 | Abandoned |
Array
(
[id] => 11589917
[patent_doc_number] => 20170114328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHOD FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELLS FROM ADIPOSE-DERIVED MESENCHYMAL STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS MANUFACTURED BY SAME METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/317606
[patent_app_country] => US
[patent_app_date] => 2014-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4833
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317606
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317606 | Method of making human cells expressing OCT4, SOX2, and Nanog using an Ecklonia cava extract | Jun 24, 2014 | Issued |
Array
(
[id] => 10905738
[patent_doc_number] => 20140308746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/311545
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 83516
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14311545
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/311545 | Induced pluripotent stem cells with synthetic modified RNAs | Jun 22, 2014 | Issued |
Array
(
[id] => 10974725
[patent_doc_number] => 20140377760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES'
[patent_app_type] => utility
[patent_app_number] => 14/311368
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 44532
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14311368
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/311368 | METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES | Jun 22, 2014 | Abandoned |
Array
(
[id] => 9792669
[patent_doc_number] => 20150004612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'METHODS AND COMPOSITIONS FOR PRODUCING INDUCED AIRWAY TISSUE PROGENITOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/295004
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31984
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295004
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295004 | Methods and compositions for producing induced airway tissue progenitor cells | Jun 2, 2014 | Issued |